TGF-beta treatment modulates PD-L1 and CD40 expression in proximal renal tubular epithelial cells and enhances CD8 cytotoxic T-cell responses - PubMed
TGF-beta treatment modulates PD-L1 and CD40 expression in proximal renal tubular epithelial cells and enhances CD8 cytotoxic T-cell responses
Astrid Starke et al. Nephron Exp Nephrol. 2007.
Abstract
Background/aim: TGF-beta expression is increased in immune-mediated and fibrotic renal diseases and modulates the tubulointerstitial T-cell response. We examined whether TGF-beta changes the expression of PD-L1 and CD40 in the renal proximal tubular epithelial cell (TEC), and whether the activation of CD8(+) cytotoxic T cells (CTLs) is influenced by TGF-beta treatment of TECs.
Methods: Murine TECs were treated with TGF-beta or IFN-gamma. The expression of PD-L1 and CD40 was examined with RT-PCR and flow cytometry. To investigate if TGF-beta treatment influenced the antigen presentation capacity of TECs, OT-1 CTLs were co-incubated with TGF-beta-treated, OVA(257-264) peptide-pulsed congeneic TECs. The cytotoxicity of OT-1 CTLs was estimated by their capacity to produce IFN-gamma and their cytolytic activity.
Results: TGF-beta treatment lead to a transition in morphology of renal TECs and downregulated the basal and the IFN-gamma-stimulated PD-L1 expression in TECs. Interestingly, TGF-beta treatment of TECs increased the constitutive and IFN-gamma-induced CD40 expression. In contrast to IFN-gamma which reduced the CTL activity, TGF-beta treatment of TECs elevated the OVA-specific CTL response.
Conclusion: Our data show that TGF-beta changed the cellular phenotype and the expression of PD-L1 and CD40 on TECs and enhanced the activity of OVA peptide-specific CD8(+) T cells. TGF-beta may thereby play an important role in the progression of renal tubulointerstitial damage in CD8(+) T-cell-mediated renal diseases.
Copyright 2007 S. Karger AG, Basel.
Similar articles
-
PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y, Starke A, Wüthrich RP. Waeckerle-Men Y, et al. Nephrol Dial Transplant. 2007 Jun;22(6):1527-36. doi: 10.1093/ndt/gfl818. Epub 2007 Mar 5. Nephrol Dial Transplant. 2007. PMID: 17339272
-
Waeckerle-Men Y, Starke A, Wahl PR, Wüthrich RP. Waeckerle-Men Y, et al. Kidney Blood Press Res. 2007;30(6):421-9. doi: 10.1159/000110578. Epub 2007 Oct 26. Kidney Blood Press Res. 2007. PMID: 17975322
-
Expression of B7-H1 in inflammatory renal tubular epithelial cells.
Chen Y, Zhang J, Li J, Zou L, Zhao T, Tang Y, Wu Y. Chen Y, et al. Nephron Exp Nephrol. 2006;102(3-4):e81-92. doi: 10.1159/000089686. Epub 2005 Nov 11. Nephron Exp Nephrol. 2006. PMID: 16282703
-
Immunological function of tubular epithelial cells: the functional implications of CD40 expression.
van Kooten C, Woltman AM, Daha MR. van Kooten C, et al. Exp Nephrol. 2000 Jul-Oct;8(4-5):203-7. doi: 10.1159/000020669. Exp Nephrol. 2000. PMID: 10940717 Review.
-
Tubular epithelial cells: A critical cell type in the regulation of renal inflammatory processes.
van Kooten C, Daha MR, van Es LA. van Kooten C, et al. Exp Nephrol. 1999 Sep-Dec;7(5-6):429-37. doi: 10.1159/000020622. Exp Nephrol. 1999. PMID: 10559641 Review.
Cited by
-
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer.
Zhang H, Dai Z, Wu W, Wang Z, Zhang N, Zhang L, Zeng WJ, Liu Z, Cheng Q. Zhang H, et al. J Exp Clin Cancer Res. 2021 Jun 4;40(1):184. doi: 10.1186/s13046-021-01987-7. J Exp Clin Cancer Res. 2021. PMID: 34088360 Free PMC article. Review.
-
Yin Z, Fan J, Xu J, Wu F, Li Y, Zhou M, Liao T, Duan L, Wang S, Geng W, Jin Y. Yin Z, et al. Front Immunol. 2020 Aug 28;11:2024. doi: 10.3389/fimmu.2020.02024. eCollection 2020. Front Immunol. 2020. PMID: 32983146 Free PMC article. Review.
-
Regulation of PD-L1 expression in the tumor microenvironment.
Yi M, Niu M, Xu L, Luo S, Wu K. Yi M, et al. J Hematol Oncol. 2021 Jan 7;14(1):10. doi: 10.1186/s13045-020-01027-5. J Hematol Oncol. 2021. PMID: 33413496 Free PMC article. Review.
-
Loftus PG, Watson L, Deedigan LM, Camarillo-Retamosa E, Dwyer RM, O'Flynn L, Alagesan S, Griffin M, O'Brien T, Kerin MJ, Elliman SJ, Barkley LR. Loftus PG, et al. Int J Cancer. 2021 Mar 1;148(5):1245-1259. doi: 10.1002/ijc.33383. Epub 2020 Dec 2. Int J Cancer. 2021. PMID: 33152121 Free PMC article.
-
Haller ST, Kumarasamy S, Folt DA, Wuescher LM, Stepkowski S, Karamchandani M, Waghulde H, Mell B, Chaudhry M, Maxwell K, Upadhyaya S, Drummond CA, Tian J, Filipiak WE, Saunders TL, Shapiro JI, Joe B, Cooper CJ. Haller ST, et al. Kidney Int. 2017 Feb;91(2):365-374. doi: 10.1016/j.kint.2016.08.015. Epub 2016 Sep 28. Kidney Int. 2017. PMID: 27692815 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials